TNF and Alzheimer disease: For example, longitudinal changes in TNFα, IL-8, and AD biomarkers in plasma along with a nerve growth factor (NGF) metabolism dysregulation could predict prospective cognitive decline in a population of DS individuals asymptomatic for AD (Iulita and Cuello, 2016).